• Login
    Search 
    •   RD&E Research Repository Home
    • Medical Services
    • Search
    •   RD&E Research Repository Home
    • Medical Services
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 41

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    • A review of national guidelines for management of COPD in Europe. 

      Miravitlles, M; Vogelmeier, C; Roche, N; Halpin, David M; Cardoso, J; Chuchalin, A G; Kankaanranta, H; Sandström, T; Śliwiński, P; Zatloukal, J; Blasi, F (European Respiratory Society, 2016-02)
      The quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant ...
    • Diagnosis, assessment, and phenotyping of COPD: beyond FEV1 

      Finch, D; Lange, P; Halpin, David M; O’Donnell, D; MacNee, W (Dove Press, 2016-02-18)
      COPD is now widely recognized as a complex heterogeneous syndrome, having both pulmonary and extrapulmonary features. In clinical practice, the diagnosis of COPD is based on the presence of chronic airflow limitation, as ...
    • Case finding for chronic obstructive pulmonary disease in people attending long-term condition clinics in primary care. 

      Halpin, David M; Holmes, S.; Calvert, J.; McInerney, D. (Sage, 2016-04-12)
      Despite increased interest and awareness of chronic obstructive pulmonary disease (COPD), nearly half of the people with COPD remain undiagnosed. Inviting people at risk for screening is unlikely to be effective as many ...
    • Working together to go ‘beyond the pill’: building a virtuous network of collaborators 

      Halpin, David M; Banks, L; Martello, A (BMJ, 2016-01-19)
    • Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. 

      Halpin, David M; Kaplan, A G; Russell, R K (Elsevier, 2017-07)
      Chronic obstructive pulmonary disease (COPD) and asthma are leading causes of morbidity and mortality. This narrative review provides an appraisal of the pharmacological and clinical characteristics of tiotropium in COPD ...
    • Safety and tolerability of once-daily tiotropium Respimat® as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis 

      Dahl, R.; Engel, M.; Dusser, D.; Halpin, David M; Kerstjens, H.A.M.; Zaremba-Pechmann, L.; Moroni-Zentgraf, P.; Busse, W. W.; Bateman, E. D. (Elsevier, 2016-07-02)
    • Clinical features should be used to assess asthma–COPD overlap 

      Halpin, David M (2016-06-16)
    • The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial 

      Paggiaro, P.; Halpin, David M; Buhl, R.; Engel, M.; Zubek, V. B.; Blahova, Z.; Moroni-Zentgraf, P.; Pizzichini, E. (Elsevier, 2015-11-07)
      BACKGROUND: Tiotropium, a once-daily long-acting anticholinergic bronchodilator, has demonstrated efficacy in patients with asthma who were symptomatic despite treatment with medium- to high-dose inhaled corticosteroids ...
    • Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. 

      Halpin, David M; Kerkhof, M.; Soriano, J.B.; Mikkelsen, H.; Price, D.B. (BioMed Central, 2016-09-23)
      Management guidelines of chronic obstructive pulmonary disease (COPD) are mainly based on results of randomised controlled trials (RCTs), but some authors have suggested limited representativeness of patients included in ...
    • Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease. 

      Singh, D.; Roche, N.; Halpin, David M; Agusti, A.; Wedzicha, J. A.; Martinez, F. J. (American Thoracic Society, 2016-09-01)
      Clinical phenotyping is currently used to guide pharmacological treatment decisions in chronic obstructive pulmonary disease (COPD), a personalized approach to care. Precision medicine integrates biological (endotype) and ...
    • 1
    • 2
    • 3
    • 4
    • . . .
    • 5

    Browse

    All of RD&E Research RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Discover

    Author
    Halpin, David M (41)
    Calvert, J. (3)Decramer, M. (3)Holmes, S. (3)McInerney, D. (3)Metzdorf, N. (3)Miravitlles, M. (3)Moroni-Zentgraf, P. (3)Roche, N. (3)Agusti, A. (2)... View MoreSubjectRespiratory medicine (33)Administration, Inhalation (1)Adrenergic beta-Agonists (1)Adult (1)Aged (1)Androstadienes (1)Benzyl Alcohols (1)Bronchodilator Agents (1)Chlorobenzenes (1)decision step process (1)... View MoreDate Issued2018 (12)2016 (11)2015 (6)2014 (5)2017 (5)2019 (1)2020 (1)Has File(s)No (29)Yes (12)

    DSpace software copyright © 2002-2021  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV